Catalyst Wire Dossier Catalyst Wire Dossier

Sugammadex

sugammadex · Merck Sharp & Dohme Corp.
Drug timelines are a Plus or Pro feature.

173 regulatory and trial events tracked for Sugammadex, covering 2010-06-11 to 2026-07-28. Get the full timeline:

Most recent: FDA Approved: SUGAMMADEX — Original Application (Mylan Institutional LLC)

See pricing